Matches in DBpedia 2014 for { ?s ?p Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed by Gilead Sciences. After completing Phase III clinical trials, on Feb 10, 2014 Gilead filed for U.S. Approval of a Ledipasvir/Sofosbuvir Fixed-Dose combination tablet for Genotype 1 Hepatitis C.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Ledipasvir comment "Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed by Gilead Sciences. After completing Phase III clinical trials, on Feb 10, 2014 Gilead filed for U.S. Approval of a Ledipasvir/Sofosbuvir Fixed-Dose combination tablet for Genotype 1 Hepatitis C.".